Company intelligence
Barrington James
About Barrington James
The global Life Sciences industry is dominant in today’s world. Drug development processes are progressing faster than ever before. The need for vaccines, treatments and medical devices continues to grow at an exponential rate to ensure treatment for disease reaches those it needs to. That means for Barrington James, we grow at the same speed. With 14 global offices specialising in niche areas of the Life Science industry, we are ready to support our growing group of clients in sourcing the most, senior, specialist and rare candidates to join them. ‘We Invest In Our People’ through training and development, through meritocratic progression, and through unrivalled commission structures, shareholder and bonus schemes. Barrington James Board & Executive Partners Barrington James is your global and award- winning Life Science Executive recruitment partner. With combined experience of over 100 years, our Executive Search team has access to the deepest pharmaceutical networks. Our primary focus is to understand and address the business challenges and hiring needs of our clients through a range of bespoke services, including Executive Search, Project Management, Market Research, Mapping Practice and Reference Check Insights.
Verified activity
Signals from Barrington James
16 published signals
People
Barrington James is recruiting for a HEOR Market Access Contractor for Cardiology and Paediatric Pain Management with a contract length of 12 months and a flexible FTE.
Reported by Alicia Chacksfield
People
Barrington James is recruiting a Project / Alliance Manager for a Mandarin and English-speaking role for a biotech client working in a China-based partner environment.
Reported by Holly Wallner
People
Barrington James is hiring Raleigh-based professionals for an upcoming Assessment Day in the Raleigh office.
Reported by Joshua Crossley
Research & Knowledge
Barrington James published a September Market Signals round-up covering five shifts across life sciences, including regulatory affairs, orphan drug approvals, and CDMOs.
Reported by Barrington James
People
Barrington James is hiring an experienced HOLC/ NTCO to join a leading UK research organisation for ASPA regulatory oversight, Home Office liaison, training and competency, licensing and animal welfare.
Reported by Hannah S.
People
Barrington James employee Ethan Dumoulin secured a specialist compounding pharmacy placement for a candidate with technical skill and hands-on compounding experience.
Reported by Barrington James
People
Barrington James is hiring a full-time SR Manager or AD Regulatory CMC Contractor for Rare Disease Biotech in the West Coast for regulatory CMC execution for a late stage mAb.
Reported by Holly Wallner
People
Barrington James is hiring a full-time MSAT contractor for a Top CGT Biotech contract in the UK and Europe for drug product for cell-based therapies.
Reported by Holly Wallner
People
Barrington James is hiring a medical writer for a Neuro client based in the UK or Europe with a 50-100% FTE for a 12-month contract.
Reported by Holly Wallner
Presence & Recognition
Barrington James reported deal-hungry-lilly-strikes-up-to-29b-immuno-activity-7500908306966892545
Reported by Jack Harvey
People
Barrington James is hiring for a Clinical operations consultant with a Sr CTM position on site in Hepatology.
Reported by Benjamin Welsh
People
Barrington James is hiring for a Clinical operations consultant with US Remote experience.
Reported by Benjamin Welsh
People
Barrington James is hiring for a Clinical operations consultant with CPM experience.
Reported by Benjamin Welsh
People
Barrington James is hiring for a permanent MSAT position in Switzerland with drug substance expertise and upstream/downstream experience.
Reported by Holly Wallner
Presence & Recognition
Barrington James is hosting an Assessment Day in its Horsham HQ and taking it across the pond to the Raleigh office.
Reported by Joshua Crossley
People
Barrington James is hiring a freelance pregnancy safety and pharmacoepidemiology expert to support FDA postmarketing requirements for pregnancy safety studies, pregnancy registry design, and feasibility assessments.
Reported by Alicia Chacksfield